Quality Hits at Lightning Speed
Unleash accelerated hit identification with Evotec’s high-throughput screening.
Drug discovery is a fundamental aspect of the pharmaceutical industry that requires meticulous research and experimentation. One critical step in drug discovery is hit identification, the process of finding chemically attractive small molecules that show a desirable biological profile.
Please find below our parts 1 and 2 of the series available on-demand. Our newest episode 3 on biophysical screening in drug discovery is now available for registration below.
Pt 1 - High Throughput Screening Strategies - Available On-Demand
Unlocking High Throughput Hit Identification Strategies
In today's dynamic landscape of drug discovery, the quest for high-quality chemical starting points is paramount.
Join us as Dr. Thomas Ahrens, Group Leader, Hit ID & Biophysics at Evotec, shares invaluable insights into the innovative strategies driving high throughput screening (HTS) processes.
The Q&A session is joined by Dr. Helene Jousset Sabroux, Group leader, High Throughput Biology & Screening at Evotec.
During this engaging session, you'll gain:
- In-depth understanding of the HTS process at Evotec.
- Insights into the challenges posed by today's HTS landscape.
- Strategies for mitigating risks in drug discovery projects.
- A glimpse into Evotec's approach to delivering the best compound starting points to our partners.
Get to Know Our Speaker
Pt 2 - Protein Sciences - Available On-Demand
It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery
At Evotec, we believe that we are living in a golden age of technological advances, with breakthrough technologies in AI/ML, screening, structural biology, biophysics and beyond. Together with our partners, we support various drug discovery programs and getting the right protein is often critical for success.
Join us as Dr. James Errey, VP, Head of Global Protein Production, discusses the innovative technologies driving protein reagent generation for drug discovery at Evotec. James will share a range of case studies providing practical insights and real-world applications of GPCR structural biology, protein biologics, membrane protein biophysics and high-throughput screening.
Get to Know Our Speaker
Pt 3 - Biophysics - Register Now
Molecular Interactions Matter - Biophysical Screening for Early Drug Discovery
Evotec’s biophysics platform supports drug discovery projects in the use of sophisticated binding and functional techniques to measure the molecular interactions between initial hit compounds and their targets with high throughput, accuracy, and precision. A growing range of biophysical techniques are specifically applied during hit identification.
Join us as Dr. Florian Krieger, VP Biophysics, presents Evotec’s most recent developments in biophysical screening approaches during early drug discovery stages, including an introduction to Evotec’s library sets suitable for biophysical screening. Florian will further discuss case studies covering lead-like screening, fragment-based approaches, and covalent hit identification.
Date: 9 July 2024
Time: The webinar is available in multiple time zones. Please select the option that best meets your needs.
9am CET | 8am BST | 3am EST | 12am PST | 4pm JST
5pm CET | 4pm BST | 11am EST | 8am PST | 12am JST
